FDA advisers to weigh Pfizer COVID-19 vaccine for young kids
(Reuters) - An expert panel will weigh the authorization of Pfizer Inc. and BioNTech's COVID-19 vaccine for children aged 5 to 11 on Tuesday as it prepares to vote on a recommendat…
(Reuters) - An expert panel will weigh the authorization of Pfizer Inc. and BioNTech's COVID-19 vaccine for children aged 5 to 11 on Tuesday as it prepares to vote on a recommendat…